Replies to post #49820 on Delcath Systems Inc (DCTH)

[nealhugh]

Mr. Purpura stated, “I am excited to guide the Company through a transformative period as we prepare to release top-line data from the Phase 3 FOCUS trial in metastatic ocular melanoma by year-end 2020 and resubmit our NDA next year.”
###
Two events of importance.
Year end is 12/20.
FDA approval possible 2021.
IS PAZDUR still at FDA??? He hated Hobbs and DCTH last time at FDA. We were there: 16-0 'fixed' results against DCTH.